Narrow search
Showing 1 - 6 of 6
Cover Image
Do health insurers posses monopsony power in the hospital services industry?
Bates, Laurie J.; Santerre, Rexford E. - In: International journal of health care finance and economics 8 (2008) 1, pp. 1-11
Persistent link: https://www.econbiz.de/10003663057
Cover Image
The impact of subsidized health insurance for the poor : evaluating the Colombian experience using propensity score matching
Trujillo, Antonio J.; Portillo, Jorge E.; Vernon, John A. - In: International journal of health care finance and economics 5 (2005) 3, pp. 211-239
Persistent link: https://www.econbiz.de/10003016860
Cover Image
Generic utilization rates, real pharmaceutical prices, and research and development expenditures
Cook, Joseph P.; Hunter, Graeme; Vernon, John A. - 2010
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act...
Persistent link: https://www.econbiz.de/10003936940
Cover Image
What's the "interest" in FDA drug advisory committee conflicts of interest?
Golec, Joseph; Vernon, John A. - 2009
Persistent link: https://www.econbiz.de/10003841414
Cover Image
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Cook, Joseph P. - 2010
Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) in 1984. In the year Hatch-Waxman was enacted, generic utilization rates were 19 percent; in contrast, today, the generic utilization rate is...
Persistent link: https://www.econbiz.de/10012462928
Cover Image
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Cook, Joseph P. - 2013
Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) in 1984. In the year Hatch-Waxman was enacted, generic utilization rates were 19 percent; in contrast, today, the generic utilization rate is...
Persistent link: https://www.econbiz.de/10013095140